Surrozen, Inc. Common

SRZNNASDAQ • USD
25.48 USD
↘ 0.27 (1.05%)AT CLOSE (03:59 PM EDT)
25.44
↘ 0.05 (0.18%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
25.44
↘ 0.05 (0.18%)
🔴Market: CLOSED

SRZN is currently priced at $25.48. SRZN shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, exceptional Return on Equity (160.2%) and a bearish Death Cross on the long-term moving averages. On the valuation front, SRZN trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.

Technical & fundamental data as of Oct 23, 2026.

Open?$25.11
High?$26.79
Low?$24.56
Prev. Close?$25.75
Volume?1.6M
Avg. Volume?866.3K
VWAP?$25.36
Rel. Volume?1.79x
Bid / Ask
Bid?$22.00 × 100
Ask?$37.50 × 200
Spread?$15.50
Midpoint?$29.75
Valuation & Ratios
Market Cap?302.7M
Shares Out?N/A
Float?8.5M
Float %?72.0%
P/E Ratio?N/A
P/B Ratio?-1.38
EPS?-$29.80
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).
Employees
44
Market Cap
302.7M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2021-08-12
Address
171 OYSTER POINT BLVD
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-475-2820
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
50
Short Sent.?
29
Piotroski F-Score?2/9Weak
Altman Z-Score?-6.90Distress
Confidence?63%Moderate
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?25.89%Squeeze Risk
Short Interest?2.2M
Days to Cover?1.5
Free Float8.5M
Avg Daily Volume1.5M
Settlement Date2026-09-30
Financial Health
Current Ratio?12.14Strong
Quick Ratio?12.14Strong
Cash Ratio?11.32Strong
Debt/Equity?-0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
S&P
97
-1.38CHEAP▾
P/S?
Peers
100
S&P
3
26.29HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-4.6CHEAP▾
EV/Sales?
Peers
100
S&P
3
17.43HIGH▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
160.2%STRONG▾
ROA?
S&P
3
-303.0%WEAK▾
Cash Flow & Enterprise
FCF?$-34984000
Enterprise Value?$200.6M
Fundamentals ratios updated end of day